Restoring the lipid molecule erucamide via nanoparticles activates immune cells to slow retinal degeneration and vision loss.

Aquaporin-4 genetic variants interact with short sleep to accelerate grey matter loss linked to early Alzheimer's disease.

A new Alzheimer's case report reveals that a single dose of psilocybin temporarily restored speech and movement in an ...

Neurosurgeons achieve first-in-human implant of Paradromics' wireless Connexus BCI to restore speech in ALS patient.

USC launches its historic first psilocybin clinical trial, tracking how an 8-week mindfulness meditation program enhances ...

Active hormone pills in oral contraceptives can increase emotional eating and binge risks in vulnerable women.

Summary: Adding probiotic therapy to standard care can provide modest but meaningful relief for older adults suffering from ...

Researchers discover rotating spiral brain waves that travel across cortical networks, acting as a space-and-time clock for ...

A new study links glucosamine supplements to a 25% higher risk of progressing from MCI to Alzheimer's disease.

A new study shows how childhood trauma, poverty, and isolation alter brain structures to trigger schizophrenia risk.

A massive 10-year population study reveals that neovascular age-related macular degeneration (nAMD) is linked to an increased ...

A new study study using NIH Fitbit data reveals that GLP-1 weight loss drugs trigger a significant drop in muscle-preserving ...